Differences in hormonal levels between heterozygous CYP21A2 pathogenic variant carriers, non-carriers, and females with non-classic congenital hyperplasia
ABSTRACT Objective: CYP21A2 mutation heterozygote carriers seem to have an increased risk of hyperandrogenism. However, the clinical relevance of the heterozygote carrier status and the reliability of hormonal testing in discriminating a carrier from a non-carrier are puzzling questions. We aimed t...
Kaydedildi:
| Asıl Yazarlar: | , , , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Sociedade Brasileira de Endocrinologia e Metabologia
2022-03-01
|
| Seri Bilgileri: | Archives of Endocrinology and Metabolism |
| Konular: | |
| Online Erişim: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S2359-39972022000200168&tlng=en |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|